NCT00283829View on ClinicalTrials.gov

Immunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

September 30, 2002

Study Completion Date

July 31, 2006

Conditions

Prostate Cancer

Interventions

DRUG

docetaxel

chemotherapy

DRUG

IL2

immunotherapy

Trial Locations (1)

98109

Seattle Cancer Care Alliance, Seattle

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Sanofi

INDUSTRY

lead

University of Washington

OTHER